Shugan Jieyu capsules for depression
Part of Mental health clinical trials.
This study tests whether Shugan Jieyu capsules, a Chinese herbal medicine, can safely and effectively treat depression. It looks at how well the capsules work and any side effects, with the goal of offering an alternative treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with depression by a doctor (using DSM-5 criteria).
- You are between 13 and 65 years old.
- You have not taken any antidepressants for at least 14 days before the study starts (or at least 28 days if you took fluoxetine).
- You are willing to sign a consent form and follow the study schedule, including visits and tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial studies Shugan Jieyu Capsule to treat generalized anxiety disorder (GAD). It aims to see if it can reduce anxiety symptoms in people who fit specific anxiety severity and traditional diagnosis criteria.
This study tests a new tablet made from a plant compound for people with moderate to severe depression. It aims to see if the treatment is safe and helps improve mood, and may be an option for those who have not tried many other antidepressants.
This trial tests a new capsule called Buagafuran for adults with generalized anxiety disorder (GAD). It aims to see if the medication helps reduce anxiety without causing major side effects.
This study tests an herbal capsule (Jieyu Chufan) for treating depression. It compares the capsule to a placebo (a pill with no active ingredient) to see if it helps reduce depressive symptoms.
This trial tests a new medicine called LV232 for people with moderate to severe depression. Researchers want to find the best dose and check if it works safely.
This study tests a gentle hands-on therapy based on Traditional Chinese Medicine, called Tui Jing, to see if it improves mood and brain function in people with depression. It lasts 12 weeks and compares the therapy with a placebo.
Hear when a new Outpatients or Inpatients With Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.